Lu Timothy K
SEC insider (Form 3/4/5 filer). CIK 0001852301. CEO at Senti Biosciences Holdings, Inc. (SNTI). 7 reported Form 4/5 transactions since Sep 2024; latest on Oct 21, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Lu Timothy K has filed insider reports for
- Senti Biosciences Holdings, Inc. (SNTI): Director, Officer, CEO
Lu Timothy K
CIK: 0001852301
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Senti Biosciences Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Oct 21, 2026SNTI
Senti Biosciences Holdings, Inc.
Tax PaymentDirect157.3K shares- - Mar 9, 2026SNTI
Senti Biosciences, Inc.
Tax PaymentDirect80.7K shares- - Feb 2, 2026SNTI
Senti Biosciences, Inc.
Tax PaymentDirect4.2K shares- - Mar 7, 2025SNTI
Senti Biosciences, Inc.
AwardDirect642.4K shares- - Mar 6, 2025SNTI
Senti Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
1.9M shares- - Feb 6, 2025SNTI
Senti Biosciences, Inc.
SaleDirect545 shares at avg. $4.36$2K - Feb 4, 2025SNTI
Senti Biosciences, Inc.
SaleDirect3.9K shares at avg. $4.07$16K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 21, 2026 | SNTI Senti Biosciences Holdings, Inc. | Tax Payment | 157,312 | - | $0 | Direct |
| Mar 9, 2026 | SNTI Senti Biosciences, Inc. | Tax Payment | 80,666 | - | $0 | Direct |
| Feb 2, 2026 | SNTI Senti Biosciences, Inc. | Tax Payment | 4,191 | - | $0 | Direct |
| Mar 7, 2025 | SNTI Senti Biosciences, Inc. | Award | 642,358 | - | - | Direct |
| Mar 6, 2025 | SNTI Senti Biosciences, Inc. | Award Stock Option (Right to Buy) | 1,927,073 | - | - | Direct |
| Feb 6, 2025 | SNTI Senti Biosciences, Inc. | Sale | 545 | $4.36 | $2,376 | Direct |
| Feb 4, 2025 | SNTI Senti Biosciences, Inc. | Sale | 3,922 | $4.07 | $15,963 | Direct |
1-7 of 7 transactions